Last update :
07/10/2024
Cardiotonic   Digoxin  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cardixin Egypt
Celoxin India
Digibind Australia, Finland, Great Britain, New Zealand, United States of America
Digocard Argentina
Digosin Japan
Digossina Italy
Digoxin Argentina, Canada, Finland, Great Britain, Hungary, Iran, Poland, Sweden, United States of America
Digoxina Argentina, Chile, Ecuador, Peru, Spain, Venezuela
Digoxine France, Greece, Romania, Switzerland, Turkey
Dixin India
Geoxin India
Gonet Mexico
Lanacrist Sweden
Lanibos Saudi Arabia
Lanicor Germany
Lanoxin Australia, Belgium, Chile, Egypt, Great Britain, Iran, Ireland, Italy, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Norway, Portugal, Saudi Arabia, United Arab Emirates, United States of America
Loxinan Mexico
Stability in solutions   injection   Stability in solutions : Digoxin     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 2,5 µg/ml 23-26°C Light
48 Hour
618
Biological analysis

Glass NaCl 0,9% or Glucose 5% 2,5 µg/ml 4°C Protect from light
48 Hour
618
Biological analysis

Glass Sodium chloride 0,9% 50 µg/ml 23-27°C Light
180 Day
4690
Level of evidence B+

Glass Sodium chloride 0,9% 50 µg/ml 3-7°C Light
180 Day
4690
Level of evidence B+

Glass Ringer’s lactate solution 2,5 µg/ml 23°C-26°C Light
6 Hour
618
Biological analysis


  Mentions Légales